Startups
Nanofuse is a regenerative therapeutic that has the properties of replacing or "regenerating" human bone cells to form normal bone.
NanoFUSE Biologics products contain the only bioactive glass that is FDA-Cleared to be combined with demineralized bone matrix (DBM). The regenerative efficacy comes from the osteoinductivity of the DBM component plus the osteopromotivity of the bioactive glass.
Bioactive glass has been clinically proven for over 30 years but only until now has NanoFUSE Biologics used bioactive glass to create a revolutionary and patented regenerative therapeutic.
NanoFUSE Biologics products contain the only bioactive glass that is FDA-Cleared to be combined with demineralized bone matrix (DBM). The regenerative efficacy comes from the osteoinductivity of the DBM component plus the osteopromotivity of the bioactive glass.
Bioactive glass has been clinically proven for over 30 years but only until now has NanoFUSE Biologics used bioactive glass to create a revolutionary and patented regenerative therapeutic.
Overview
Location
United States, Massachusetts, Malden
Employees
11-50
Founded date
2018
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2024 | KIC Ventures Changing the Private Equity Paradigm: The HealthTech Investment Firm with the Most Majority-Owned Portfolio of Revenue-Generating Spine Companies | KIC Ventures, the private healthtech investment firm with the most majority-owned portfolio of spine companies KIC Ventures is transforming the private equity landscape in healthtech by focusing exclusively on spine surgery technologies and... |
| Sep 27, 2022 | NANISX LLC To Focus On ASC Spine Surgeries Hires Ex-Medtronic David Flickinger MBA As New CEO | David Flickinger CEO of NANISX LLC, a KICVentures Group Spine Company We are driven to build NANISX as the leading ASC spine company that develops world-class products plus delivers an unmatched physician to physician education experience M... |
| Sep 9, 2022 | Dr Kingsley R Chin steps down as CEO of NanoFuse Biologics LLC after merger with NANISX LLC | NanoFuse Biologics LLC merges its unique innovations in synthetic biologics with NANISX LLC NanoFuse Biologics represents the most unique and innovative advance in synthetic biologics in recent years. MALDEN, Mass. (PRWEB) September 09, 202... |
| Sep 5, 2022 | Dr Kingsley R Chin Forms New Spine Company NANISX LLC To Focus on Ambulatory Surgery Centers (ASC) | NANISX LLC innovating outpatient spine technologies for Ambulatory Surgery Centers We are dedicated to support the rise in outpatient spine surgeries by training and equipping Interventional Pain Management doctors, Orthopedic surgeons and ... |
| Jan 14, 2022 | Inspan to showcase at NANS its newly released updated instruments for the percutaneous mini-open direct posterior technique for spinal fusion and stenosis treatment | Inspan Mini Interspinous Plating System Image "Due to the advantages, Inspan is being adopted as an outpatient solution by orthopedic, neurosurgery, and pain management physicians performing spinal fusion and decompression surgeries.&q... |
| Jan 10, 2022 | Orthopedic Spine Surgeon Dr Kingsley R Chin Unprecedented Impact On Pain Management With Record 16 Clinical Abstract Presentations at NANS 2022 Annual Meeting in Orlando | "This is validation for KICVentures Group and Dr Kingsley R Chin that their spine technologies are being adopted by us in pain management fairly rapidly and the major pain management societies are accepting the clinical evidence for pr... |
| Jan 10, 2022 | Inspan LLC November 24, 2021 Groundbreaking Achievement As the FIRST Interspinous Plate Fixation Device Granted FDA Clearance for Fusion and Spinal Stenosis from T1-S1 | Spondylolisthesis with severe spinal stenosis "Inspan has given me great confidence I can treat a lot of my patients successfully as a pain physician who performs outpatient interventional spine surgery" said Dr Michael Esposito M... |
| Dec 22, 2020 | Medical Breakthrough as KICVentures Group Closes Its Land-Mark Acquisition of NanoFUSE Biologics | NanoFUSE Biologics is a world leader in synthetic biologics and is the only FDA-cleared combination of demineralized bone matrix (DBM) and bioactive glass indicated in orthopedic surgery. KICVentures Group announces a medical breakthrough i... |
Reviews 0
FAQ about NanoFUSE Biologics
When was NanoFUSE Biologics founded?
NanoFUSE Biologics was founded in 2018.
What has the press written about NanoFUSE Biologics?
Parsers VC has collected 9 articles mentioning NanoFUSE Biologics, among them “KIC Ventures Changing the Private Equity Paradigm: The HealthTech Investment Firm with the Most Majority-Owned Portfolio of Revenue-Generating Spine Companies” (Oct 8, 2024) and “NANISX LLC To Focus On ASC Spine Surgeries Hires Ex-Medtronic David Flickinger MBA As New CEO” (Sep 27, 2022).
Is NanoFUSE Biologics still active?
Yes, NanoFUSE Biologics is active; its latest activity on Parsers VC dates from Oct 22, 2024.